# Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage

> **NCT04088630** · EARLY_PHASE1 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 28 (actual)

## Conditions studied

- Intracerebral Hemorrhage
- Cerebral Edema
- Stroke Hemorrhagic
- Intracerebral Hemorrhage, Hypertensive
- Intracerebral Hemorrhage Intraparenchymal

## Interventions

- **DRUG:** Fingolimod
- **DRUG:** Placebo
- **DRUG:** Open-label Fingolimod

## Key facts

- **NCT ID:** NCT04088630
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-07
- **Primary completion:** 2023-06-30
- **Final completion:** 2024-06-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04088630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04088630, "Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04088630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*